Imis Pharmaceuticals Pvt Ltd, a active private limited company, was established on 25 June 1981 in Na, Andhra Pradesh, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24239AP1981PTC003079. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
It upholds a compliant status. Employing 158 professional, Its leadership includes Naga Lakshmi Vepakomma (Managing Director), Nagamallika Gudipaty (Director), Nagaprasuna Balantrapu (Director). Past directors included Krishna Vepakomma, Naga Lakshmi Vepakomma, Lakshminarayana Dubagunta. It holds ₹2.76 Cr open charges and ₹1.13 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 30-17-1, Seetharampuramvijayawada -520 002, Na, Andhra Pradesh.
U24239AP1981PTC003079
003079
25 June 1981
₹3.00 M
₹3.00 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Imis Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naga Lakshmi Vepakomma | Managing Director | 01 Apr 1998 | Current |
| Nagamallika Gudipaty | Director | 12 Jun 2015 | Current |
| Nagaprasuna Balantrapu | Director | 04 Aug 2017 | Current |
| Dubagunta Nagasaila | Director | 12 Jun 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Jan 2019 | Past |
| Pramod Abcsdd | Director | 22 Aug 2020 | Past |
| Pramod Abcsdd | Managing Director | 13 Jul 2010 | Past |
| Pramod Abcsdd | Director | 04 Aug 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Imis Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 36.11% increase. The company also saw a substantial fall in profitability, with a 20.75% decrease in profit. The company's net worth moved up by a moderate rise of 7.47%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Imis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹27,642,000.00
₹11,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 May 2009 | Indian Overseas Bank | ₹2.76 Cr | Open |
| 15 Dec 2008 | Andhra Bank | ₹3.00 M | Satisfied |
| 20 Jan 2005 | Andhra Bank | ₹0.65 M | Satisfied |
| 28 May 2004 | Andhra Bank | ₹1.80 M | Satisfied |
| 29 Dec 1994 | Andhra Bank | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Imis Pharmaceuticals has a workforce of 158 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Imis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Imis Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Imis Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was completed.
Progress on A charge with Indian Overseas Bank of Rs. 27.64 M registered on 15 May 2009 with Charge ID 10164902 was modified on 06 Oct 2023. was documented.
Nagaprasuna Balantrapu was appointed as a Director was appointed as a Director on 04 Aug 2017 & has been associated with this company since 8 years 3 months . was recorded as a recent event.
Nagamallika Gudipaty was appointed as a Director was appointed as a Director on 12 Jun 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.
Progress on Dubagunta Nagasaila was appointed as a Director was appointed as a Director on 12 Jun 2015 & has been associated with this company since 10 years 5 months . was documented.
The CIN of Imis Pharmaceuticals Pvt Ltd is U24239AP1981PTC003079.
Imis Pharmaceuticals Pvt Ltd is headquartered at 30-17-1, Seetharampuramvijayawada -520 002, Na, Andhra Pradesh.
Imis Pharmaceuticals Pvt Ltd was incorporated on 25 June 1981.
The current directors of Imis Pharmaceuticals Pvt Ltd are
The primary industry of Imis Pharmaceuticals Pvt Ltd is Manufacturing.
Imis Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Imis Pharmaceuticals Pvt Ltd is ₹3.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Imis Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX